ArticleCirculation. Cardiovascular quality and outcomes2015
Building the case for novel clinical trials in pulmonary arterial hypertension.
Article in Circulation. Cardiovascular quality and outcomes, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.American journal of respiratory and critical care medicine · 2017Guideline
- The sine transform is theFrontiers in cardiovascular medicine · 2023Article
- Safety and tolerability of combination therapy with ambrisentan and tadalafil for the treatment of pulmonary arterial hypertension in children: Real-world experience.Pediatric pulmonology · 2022Observational
- Enrichment Benefits of Risk Algorithms for Pulmonary Arterial Hypertension Clinical Trials.American journal of respiratory and critical care medicine · 2021Article
- Pulmonary arterial hypertension: Rationale for using multiple vs. single drug therapy.Global cardiology science & practice · 2020Review
- The emerging role of epigenetics in pulmonary arterial hypertension: an important avenue for clinical trials (2015 Grover Conference Series).Pulmonary circulation · 2016Review
- Update in Pulmonary Vascular Disease 2015.American journal of respiratory and critical care medicine · 2016Review
- Where do we go from here? Reappraising the data on anticoagulation in pulmonary arterial hypertension.Journal of thoracic disease · 2016Article
- Clinical trial design in phase 2 and 3 trials for pulmonary hypertension.Pulmonary circulationArticle
- Early intervention: should we conduct therapeutic trials for mild pulmonary hypertension before onset of symptoms?Pulmonary circulationArticle
- Combination therapy in pulmonary arterial hypertension: recent accomplishments and future challenges.Pulmonary circulationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.